Medmal (Medical malpractice)
-
Despite mild headline CPI, some insurance-related items are heading in a worrying direction. -
An industry veteran of 34 years, the executive is known for placing US healthcare business in London.
-
Rising inflation could raise claims severity but also increase investment income.
-
PL coverage is being stripped out of admitted, packaged policies and increasingly purchased in the E&S market.
-
The FTC granted early termination of the waiting period, leaving the acquisition on track to finish in early 2026.
-
The vote paves the way for the finalization of the deal in the first half of 2026.
-
Tariffs could drive up property loss costs, but the impact on other items has been muted.
-
The impact of SAM claims is reverberating through the tower and the broader marketplace beyond hospitals.
-
A deep-dive analysis shows LitFin is not the boogeyman this industry paints it out to be.
-
The Insurance Insider US news team runs you through this week’s key agency M&A.
-
What insurers can learn from the history that led to this deal.
-
ProAssurance brands will be transitioned to The Doctors Company in "all/most markets" over time.
Related
-
The Doctors Company to buy ProAssurance in $1.3bn deal
March 19, 2025 -
Medical PL market is ‘awash with capital’: ProAssurance CEO
February 25, 2025 -
Nuclear medmal verdicts: Is $50mn the new $25mn?
February 24, 2025 -
Sexual abuse and molestation claims drive tightening medmal market
November 19, 2024